EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

2,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma

Philipp N Becker iD, Vera A Kulow iD, Claudia S Czopek, Kameliya Roegner, Gohar Ter-Avetisyan, Anica Loth, Bianca Nitzsche iD, Cem Erdogan, Adrian Schreiber, Michael Höpfner iD, Michael Fähling iD, Robert Labes iD

Cells · 31.03.2026 · 15 (7) · 633

DOI: 10.3390/cells15070633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 31.03.2026. Verfasst von Philipp N Becker und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Translationale Physiologie (CCM), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universi…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Transcription, Genetic, Phosphoglycerate Mutase. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) is characterized by profound metabolic reprogramming and limited responsiveness to therapeutic stressors, including epigenetic modulation. How glycolytic enzymes contribute to metabolic stress tolerance in ccRCC remains incompletely understood. We investigated the role of the glycolytic enzyme 2,3-bisphosphoglycerate mutase (BPGM) using human tumor specimens, siRNA-mediated gene silencing, functional cell-based assays, and transcriptomic profiling. Epigenetic stress was induced using Vorinostat as a pan-histone deacetylase inhibitor. BPGM expression was consistently elevated in human ccRCC compared with adjacent normal kidney tissue. A498 cells exhibited high basal BPGM levels and limited sensitivity to Vorinostat, whereas BPGM depletion increased cellular stress responses and reduced proliferative capacity. Despite similar phenotypic outcomes, BPGM silencing and Vorinostat treatment triggered distinct transcriptional programs. While HDAC inhibition induced widespread transcriptional changes, BPGM loss elicited a focused stress-associated response, consistent with activation of the unfolded protein response, increased lipid peroxidation, and induction of ER stress-associated genes. Our data identify BPGM as a metabolic player contributing to stress-adaptive transcriptional states in ccRCC and suggest that targeting metabolic stress adaptation may complement epigenetic strategies in renal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsTranscription, GeneticPhosphoglycerate MutaseStress, PhysiologicalHumansCell Line, TumorGene Expression Regulation, NeoplasticMetabolic ReprogrammingHistone Deacetylase InhibitorsEpigenesis, GeneticVorinostatCell Proliferation

Stichwörter der Autor:innen

BPGMcancer metabolismclear cell renal cell carcinoma (ccRCC)epigenetic perturbationferroptosisglycolytic fluxredox homeostasisstress tolerance

Substanzen

Phosphoglycerate MutaseHistone Deacetylase InhibitorsVorinostat

Autor:innen und Institutionen

  • Institut für Translationale Physiologie (CCM), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
  • Institut für Physiologie (CCM), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
  • Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-…

ORCID-Profile: Philipp N Becker, Vera A Kulow, Bianca Nitzsche, Michael Höpfner, Michael Fähling, Robert Labes

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)

Zitieren

APA

Becker, P. N., Kulow, V. A., Czopek, C. S., Roegner, K., Ter-Avetisyan, G., Loth, A., Nitzsche, B., Erdogan, C., Schreiber, A., Höpfner, M., Fähling, M., & Labes, R. (2026). 2,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma. Cells, 15(7), 633. https://doi.org/10.3390/cells15070633

Vancouver

Becker PN, Kulow VA, Czopek CS, Roegner K, Ter-Avetisyan G, Loth A, et al. 2,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma. Cells. 2026;15(7):633. doi:10.3390/cells15070633

BibTeX
@article{Becker2026,
  author = {Becker, Philipp N and Kulow, Vera A and Czopek, Claudia S and Roegner, Kameliya and Ter-Avetisyan, Gohar and Loth, Anica and Nitzsche, Bianca and Erdogan, Cem and Schreiber, Adrian and Höpfner, Michael and Fähling, Michael and Labes, Robert},
  title = {2,3-Bisphosphoglycerate Mutase (BPGM), a Metabolic Player Shaping Stress-Adaptive Transcriptional States in Clear Cell Renal Cell Carcinoma},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {7},
  pages = {633},
  doi = {10.3390/cells15070633}
}
Kostenlos starten →